Company: CRAC
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001213900-25-062977
Chunk: 213

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-07-11
Form: S-1/A
Chunk 213
---
.50. •Kernel Group Holdings, Inc. (NASDAQ: KRNL) — Mr. Peterson has served as a director since December 2022. Mr. Fell has served as a director since December 2022. On August5, 2024, Kernel Group Holdings, Inc. issued a press release announcing it will redeem all of its outstanding Class A ordinary shares, par value $0.0001, effective as of the close of business on August5, 2024, because the company would not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. •Integrated Wellness Acquisition Corp (OTC: WELNF) — Mr. Peterson has served as director since February 2024. Mr. Fell has served as director since February 2024. The company extended the period of time it had to consummate its initial business combination by an aggregate of 33 months; however, the company has not consummated its initial business combination. •Semper Paratus Acquisition Corporation (n/k/a Tevogen Bio Holdings Inc. (NASDAQ: TVGN)) — Mr. Peterson served as director from June 2023 until the completion of its initial business combination in February 2024. Mr. Fell served as a director from June 2023 until the completion of its initial business combination in February 2024. Mr. Wadhwani has served as director since June 2023. On February14, 2024 pursuant to the agreement and plan of merger dated June28, 2023 (the “Merger Agreement”), by and among Semper Paratus Acquisition Corporation (“Semper Paratus”), Semper Merger Sub, Inc., a wholly owned subsidiary of Semper Paratus, SSVK Associates, LLC, Tevogen Bio Inc (n/k/a Tevogen Bio Inc.), and Dr. Ryan Saadi in his capacity as seller representative, Semper Merger Sub, Inc. merged with and into Tevogen Bio Inc. with Tevogen Bio Inc. being the surviving company and a wholly owned subsidiary of the Company (the “Merger,” and together with the other transactions contemplated by the Merger Agreement, the “Business Combination”), and Semper Paratus was renamed Tevogen Bio Holdings Inc. Semper Paratus held a shareholder vote to approve an extension on the time period the company had to complete the initial business combination. Director Independence Nasdaq listing standards require that a majority of our board of directors